Cover Image
Market Research Report

Intraocular Lenses (IOLs): Pipeline Analytics, Cataract Burden, Cataract Epidemiology & Epidemiology Forecast and Deals Activity from 2010 to 2019

Published by GervanoRA Data Services LLP Product code 813724
Published Content info 55 Pages
Delivery time: 1-2 business days
Price
Back to Top
Intraocular Lenses (IOLs): Pipeline Analytics, Cataract Burden, Cataract Epidemiology & Epidemiology Forecast and Deals Activity from 2010 to 2019
Published: March 22, 2019 Content info: 55 Pages
Description

‘Intraocular Lenses (IOLs): Pipeline Analytics, Cataract Burden, Cataract Epidemiology & Epidemiology Forecast and Deals Activity from 2010 to 2019’ report analyzed and assessed in detail the analytics on Intraocular Lens competitive space by covering pipeline IOLs by stage of development, equipment type, geography, Cataract disease burden (Global Cataract Burden & US Cataract Burden) and Cataract epidemiology and epidemiology forecast (2025).

Report has even provided analytics on deals activity of IOL space by covering deal types like acquisitions, mergers, partnering, collaborations, alliances and agreements from 2010 to till the date.

This report is focused to provide snapshot of drivers, restraints and opportunities in intraocular lens competitive space. All pipeline IOLs are provided with detailed descriptions and technological specifications.

Report helps clients to refine the commercial opportunities from the existing treatment armamentarium to pipeline assets, deals, and deal comparables. Even it helps in identifying the most relevant actors in the field for partnering deals.

Table of Contents
Product Code: GERMD216

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1 REPORT DESCRIPTION
  • 1.2 METHODOLOGY
  • 1.3 ABOUT US: GERVANORA DATA SERVICES

2. EXECUTIVE SUMMARY

  • 2.1 REPORT MAJOR FINDINGS
  • 2.2 DRIVERS
  • 2.3 RESTRAINTS
  • 2.4 OPPORTUNITIES

3. DISEASE OVERVIEW

  • 3.1. CATARACT OVERVIEW & PATHOGENESIS
  • 3.2 CATARACT DIAGNOSIS
  • 3.3 CATARACT TREATMENT
  • 3.4 CATARACT BURDEN
    • 3.4.1 US CATARACT BURDEN
    • 3.4.2 GLOBAL CATARACT BURDEN
  • 3.5. PROBABILISTIC EPIDEMIOLOGY FORECAST (Method & Assumptions)
    • 3.5.1. PROBABILISTIC GLOBAL CATARACT EPIDEMIOLOGY FORECAST
    • 3.5.2. PROBABILISTIC US CATARCT EPIDEMIOLOGY FORECAST

4. MARKET DYNAMICS/DEALS ACTIVITY

  • 4.1. ACQUISITION DEALS
  • 4.2 COLLABORATION DEALS
  • 4.3 LICENSING AGREEMENT DEALS
  • 4.4 PARTNERING AND ALLIANCES DEALS
  • 4.5. ORIGINAL & SUPPLEMENTAL PMA APPROVALS
  • 4.6 NEW INTERNATIONAL APPROVALS

5. PIPELINE ANALYSIS

  • 5.1. PIPELINE ANALYSIS BY STAGE OF DEVELOPMENT
    • 5.1.1. CLINICAL PIPELINE IOLs
    • 5.1.2. PRECLINICAL PIPELINE IOLs
    • 5.1.3. EARLY R&D PIPELINE IOLs
  • 5.2. PIPELINE ANALYSIS BY GEOGRAPHY
  • 5.3. PIPELINE ANALYSIS BY EQUIPMENT TYPE
  • 5.4. PIPELINE ANALYSIS BY INDICATION
  • 5.5. PIPELINE ANALYSIS BY UNIVERSITIES AND INSTITUTES

LIST OF TABLES

  • TABLE 01: GLOBAL CATARACT EPIDEMIOLOGY (2018) AND FORECAST (2019-2025)
  • TABLE 02: US CATARACT EPIDEMIOLOGY (2018) AND FORECAST (2019-2025)
  • TABLE 03: TOTAL KEY DEALS ACTIVITY IN INTRAOCULAR LENSES (IOLS) COMPETITIVE SPACE
  • TABLE 04: MAJOR ACQUISITION DEALS ACTIVITY IN INTRAOCULAR LENSES COMPETITIVE SPACE
  • TABLE 05: MAJOR COLLABORATION DEALS ACTIVITY IN INTRAOCULAR LENSES COMPETITIVE SPACE
  • TABLE 06: MAJOR LICENSING DEALS ACTIVITY IN INTRAOCULAR LENSES COMPETITIVE SPACE
  • TABLE 07: MAJOR PARTNERING & ALLIANCE DEALS ACTIVITY IN IOLS COMPETITIVE SPACE
  • TABLE 08: KEY INTERNATIONAL REGULATORY APPROVALS FOR IOLS
  • TABLE 09: SUMMARY OF PIPELINE IOLS BY STAGE OF DEVELOPMENT
  • TABLE 10: CLINICAL STAGE PIPELINE IOLS
  • TABLE 11: PRECLINICAL STAGE PIPELINE IOLS
  • TABLE 12: EARLY R&D STAGE PIPELINE IOLS
  • TABLE 13: UNITED STATES PIPELINE IOLS VS STAGE OF DEVELOPMENT
  • TABLE 14: EUROPE PIPELINE IOLS VS HIGHEST STAGE OF DEVELOPMENT (HSD)
  • TABLE 15: ACCOMMODATING IOLS VS HIGHEST STAGE OF DEVELOPMENT (HSD)
  • TABLE 16: TORIC IOLS VS HIGHEST STAGE OF DEVELOPMENT (HSD)
  • TABLE 17: PMMA & OTHER IOLS VS HIGHEST STAGE OF DEVELOPMENT (HSD)
  • TABLE 18: PIPELINE IOLS VS INDICATIONS
  • TABLE 19: PIPELINE IOLS INDICATED FOR CATARACT
  • TABLE 20: PIPELINE IOLS INDICATED FOR PRESBYOPIA
  • TABLE 21: PIPELINE IOLS INDICATED FOR ANIRIDIA
  • TABLE 22: PIPELINE IOLS INDICATED FOR MYOPIA

LIST OF FIGURES

  • FIGURE 01: GLOBAL CATARACT EPIDEMIOLOGY FORECAST (2019-2025)
  • FIGURE 02: GLOBAL CATARACT EPIDEMIOLOGY COMPARE 2018 VS 2025(POPULATION IN MILLIONS)
  • FIGURE 03: US CATARACT EPIDEMIOLOGY FORECAST (2019-2025)
  • FIGURE 04: US CATARACT EPIDEMIOLOGY COMPARE 2018 VS 2025(POPULATION IN MILLIONS)
  • FIGURE 05: DEALS (MERGERS & ACQUISITIONS) ACTIVITY IN IOLS COMPETITIVE SPACE
  • FIGURE 06: ORIGINAL PMA & SUPPLEMENTAL PMA APPROVALS SINCE 1985
  • FIGURE 07: PIPELINE IOLS BY GEOGRAPHY
Back to Top